Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma
Autor: | Anthony Al Hawat, Guillaume de Bonnecaze, Elie Serrano, Thomas Filleron, Sébastien Vergez, Benoit Chaput, Benjamin Vairel |
---|---|
Rok vydání: | 2014 |
Předmět: |
Adult
Male Nasal cavity medicine.medical_specialty Nose Neoplasms Esthesioneuroblastoma Olfactory Disease-Free Survival Postoperative Complications Overall survival Humans Medicine Endoscopic resection Olfactory esthesioneuroblastoma Craniofacial Stage (cooking) Aged Neoplasm Staging Retrospective Studies business.industry Incidence Gold standard Endoscopy Retrospective cohort study General Medicine Middle Aged Otorhinolaryngologic Surgical Procedures Surgery Survival Rate medicine.anatomical_structure Otorhinolaryngology Female France Nasal Cavity Neoplasm Recurrence Local business Forecasting |
Zdroj: | Acta Oto-Laryngologica. 134:1259-1264 |
ISSN: | 1651-2251 0001-6489 |
DOI: | 10.3109/00016489.2014.944271 |
Popis: | Endoscopic techniques seem to be safe approaches for the treatment of esthesioneuroblastomas (ENBs). However, they are intended for selected patients and require extensive experience in base of the skull surgery.ENB is a rare tumor of the nasal cavity. The craniofacial approaches remain the gold standard of treatment in multiple centers. Endoscopic endonasal approaches were progressively developed. The main objective of this work was to study the overall survival and recurrence-free period for patients with ENB who underwent endoscopic resection.We performed a retrospective study from 1996 to 2014, reviewing the patients treated by endonasal endoscopic surgery for ENB.Eight patients benefited from endoscopic surgical resection. According to the Kadish classification, one patient was stage A, three patients were stage B, and four patients were stage C. According to the Dulguerov classification, one patient was stage T1, five patients were stage T2, and two were stage T4. Reconstruction of the base of the skull was performed in three patients. No postoperative complications were noted. The mean follow-up period was 95 months. The 5-year overall survival was 87.5% and the 5-year recurrence-free survival was 75%. To date, there have been no local recurrences but two patients had lymph node recurrences. Seven patients are disease-free and one is deceased. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |